je.st
news
Tag: biotech
a Ariad is at the bottom of a big biotech food chain, at least for now
2015-09-02 03:25:22| Biotech - Topix.net
The wave of merger-mania running through the biotech industry right now appears to be as much about companies trying not to be eaten as it is about companies eager to eat.
Biotech Weekly: Reviewing The
2015-09-01 17:58:35| Biotech - Topix.net
The recent huge gains seen by holders of Aquinox Pharmaceuticals , Celsus Therapeutics , and Recro Pharma illustrate the potential of the Of the 35 names on the screen, I highlight Roka Biosciences, Nexvet Biopharma, OXiGENE, MEI Pharma, Biota Pharmaceuticals, Celladon, and Venaxis as names I like. I highlight Affymax, Tikro Technologies, Cadus Corporation, and Natural Alternatives International as potential investment opportunities, but cases where I need to do more due diligence.
Tags: weekly
reviewing
biotech
Biotech Foods Can Save People and the Environment
2015-09-01 05:18:48| Biotech - Topix.net
Approximately 800 million people are currently malnourished, and the world's population is expected to rise by 2 billion by the year 2050. If we use current technologies-or, Heaven forbid, roll back use of modern agricultural practices-we will have to plow down literally millions of acres to relieve the projected hunger expected to come as a result of the growing population.
Tags: the
people
save
environment
Phila. biotech firm to defer executive bonuses
2015-08-31 20:45:14| Biotech - Topix.net
Hemispherx Biopharma said Monday it is deferring all executive bonus payments until the Philadelphia biotechnology company achieves manufacturing goals at it newly renovated plant in North Jersey. According to documents filed with the Securities and Exchange Commission, the employment contracts for both Carter and Equels include the opportunity this year to earn bonuses of up to 25 percent of their base salary.
Tags: firm
executive
biotech
bonuses
San Francisco biotech CytomX files for $100 million IPO
2015-08-31 16:35:08| Biotech - Topix.net
San Francisco-based biotech CytomX Theraputics has filed to raise $100 million for an initial public offering, a brief with the Securities and Exchange Commission shows . The company develops cancer immunotherapies that avoid healthy cells.
Tags: san
files
million
francisco
Sites : [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] next »